Matches in Nanopublications for { ?s ?p "DDI between Tacrolimus and Atazanavir - The protease inhibitor, Atazanavir, may increase the blood concentration of Tacrolimus. Monitor for changes in the therapeutic/toxic effects of Tacrolimus if Atazanavir therapy is initiated, discontinued or altered. [drugbank_resource:DB00864_DB01072]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00864_DB01072 label "DDI between Tacrolimus and Atazanavir - The protease inhibitor, Atazanavir, may increase the blood concentration of Tacrolimus. Monitor for changes in the therapeutic/toxic effects of Tacrolimus if Atazanavir therapy is initiated, discontinued or altered. [drugbank_resource:DB00864_DB01072]" assertion.